GetTopicDetailResponse(id=5110111998, topicName=2期臨床試驗(yàn), introduction=2期臨床試驗(yàn), content=null, image=null, comments=0, allHits=1074, url=https://h5.medsci.cn/topic?id=1119, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=21897, tagList=[TagDto(tagId=21897, tagName=2期臨床試驗(yàn))], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2214636, encodeId=568b221463659, content=<a href='/topic/show?id=b3f4538049d' target=_blank style='color:#2F92EE;'>#戈舍瑞林#</a> <a href='/topic/show?id=5110111998' target=_blank style='color:#2F92EE;'>#2期臨床試驗(yàn)#</a> <a href='/topic/show?id=eb8b9e810aa' target=_blank style='color:#2F92EE;'>#阿帕魯胺#</a>, objectTitle=CLIN CANCER RES | YATAGARASU 研究：阿帕魯胺聯(lián)合戈舍瑞林治療雄激素受體陽(yáng)性涎腺癌的 2 期非隨機(jī)臨床試驗(yàn), objectType=article, longId=833699, objectId=b89d8336997d, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240708/1720445787310_6145188.png, objectUrl=/article/show_article.do?id=b89d8336997d, replyNumber=0, likeNumber=93, createdTime=2024-07-12, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=b89d8336997d, moduleTitle=CLIN CANCER RES | YATAGARASU 研究：阿帕魯胺聯(lián)合戈舍瑞林治療雄激素受體陽(yáng)性涎腺癌的 2 期非隨機(jī)臨床試驗(yàn), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=b89d8336997d)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2190542, encodeId=668a219054275, content=<a href='/topic/show?id=e101e2133b1' target=_blank style='color:#2F92EE;'>#皮膚鱗狀細(xì)胞癌#</a> <a href='/topic/show?id=5110111998' target=_blank style='color:#2F92EE;'>#2期臨床試驗(yàn)#</a> <a href='/topic/show?id=7a3e11181ea4' target=_blank style='color:#2F92EE;'>#西米普利單抗#</a>, objectTitle=Lancet Oncol | 2期臨床研究：新輔助西米普利單抗在可切除II-IV期皮膚鱗狀細(xì)胞癌患者中的安全性和療效評(píng)估, objectType=article, longId=815535, objectId=72448155354d, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240301/1709304284017_6145188.jpg, objectUrl=/article/show_article.do?id=72448155354d, replyNumber=0, likeNumber=142, createdTime=2024-03-02, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=72448155354d, moduleTitle=Lancet Oncol | 2期臨床研究：新輔助西米普利單抗在可切除II-IV期皮膚鱗狀細(xì)胞癌患者中的安全性和療效評(píng)估, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=72448155354d)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯話(huà)題小助手
2020-05-29
